[1] |
Bernstock JD,Peruzzotti-Jametti L,Ye D, et al. Neural stem cell transplantation in ischemic stroke: A role for preconditioning and cellular engineering[J]. J Cereb Blood Flow Metab, 2017, 37(7):2314-2319.
|
[2] |
Cheng Q,Zhang Z,Zhang S, et al. Human umbilical cord mesenchymal stem cells protect against ischemic brain injury in mouse by regulating peripheral immunoinflammation[J]. Brain Res, 2015, 1594: 293-304.
|
[3] |
Lo Furno D,Mannino G,Giuffrida R. Functional role of mesenchymal stem cells in the treatment of chronic neurodegenerative diseases[J]. J Cell Physiol, 2018, 233(5): 3982-3999.
|
[4] |
Isern J,Garcia-Garcia A,Martin AM, et al. The neural crest is a source of mesenchymal stem cells with specialized hematopoietic stem cell niche function[J]. ELife, 2014, 3: e03696.
|
[5] |
Jadasz JJ,Tepe L,Beyer F, et al. Human mesenchymal factors induce rat hippocampal-and human neural stem cell dependent oligodendrogenesis[J]. Glia, 2018, 66(1): 145-160.
|
[6] |
Chen J,Li Y,Wang L, et al. Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats[J]. Stroke, 2001, 32(4): 1005-1011.
|
[7] |
Li Y,Chopp M,Chen J, et al. Intrastriatal transplantation of bone marrow nonhematopoietic cells improves functional recovery after stroke in adult mice[J]. J Cereb Blood Flow Metab, 2000, 20(9):1311-1319.
|
[8] |
Hsuan YC,Lin CH,Chang CP, et al. Mesenchymal stem cell-based treatments for stroke, neural trauma, and heat stroke[J]. Brain Behav, 2016, 6(10):e00526.
|
[9] |
Hayakawa K,Esposito E,Wang X, et al. Transfer of mitochondria from astrocytes to neurons after stroke[J]. Nature, 2016, 535(7613): 551-555.
|
[10] |
Writing Group M,Mozaffarian D,Benjamin EJ, et al. Executive Summary: Heart Disease and Stroke Statistics--2016 Update: A Report From the American Heart Association[J]. Circulation, 2016, 133(4): 447-454.
|
[11] |
Kim AS,Johnston SC. Temporal and geographic trends in the global stroke epidemic[J]. Stroke, 2013, 44(6 Suppl 1): S123-125.
|
[12] |
Roullet S,Labrouche S,Mouton C, et al. Lysis Timer: a new sensitive tool to diagnose hyperfibrinolysis in liver transplantation[J]. J Clin Pathol, 2019, 72(1): 58-65.
|
[13] |
Munir H,McGettrick HM. Mesenchymal Stem Cell Therapy for Autoimmune Disease: Risks and Rewards[J]. Stem Cells Dev, 2015, 24(18): 2091-2100.
|
[14] |
Rosenberg SA,Yang JC,Restifo NP. Cancer immunotherapy: moving beyond current vaccines[J]. Nat Med, 2004, 10(9): 909-915.
|
[15] |
Vargas AJ,Harris CC. Biomarker development in the precision medicine era: lung cancer as a case study[J]. Nat Rev Cancer, 2016, 16(8): 525-537.
|
[16] |
Voloboueva LA,Suh SW,Swanson RA, et al. Inhibition of mitochondrial function in astrocytes: implications for neuroprotection[J]. J Neurochem, 2007, 102(4):1383-1394.
|
[17] |
Nzigou Mombo B,Gerbal-Chaloin S,Bokus A, et al. MitoCeption: Transferring Isolated Human MSC Mitochondria to Glioblastoma Stem Cells[J]. J Vis Exp, 2017:120.
|
[18] |
Mahrouf-Yorgov M,Augeul L,Da Silva CC, et al. Mesenchymal stem cells sense mitochondria released from damaged cells as danger signals to activate their rescue properties[J]. Cell Death Differ, 2017, 24(7): 1224-1238.
|
[19] |
Ahmad T,Mukherjee S,Pattnaik B, et al. Miro1 regulates intercellular mitochondrial transport & enhances mesenchymal stem cell rescue efficacy[J]. EMBO J, 2014, 33(9):994-1010.
|